EXELIXIS, INC. — Director's Dealing 2015

Nov 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2015-11-16

Reporting Person: Schwab Gisela (EVP and Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-16	Common Stock	M	3125	—	Acquired	92924	Direct
2015-11-16	Common Stock	F	1174	—	Disposed	91750	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-16	Restricted Stock Units	$	M	3125	Disposed		Common Stock (3125.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12078	Indirect

Footnotes

F1: Restricted stock units convert into Exelixis, Inc. common stock on a one-for-one basis.

F2: Includes 4,866 and 7,349 shares acquired under the Exelixis, Inc. 2000 Employee Stock Purchase Plan on April 30, 2015 and October 30, 2015, respectively.

F3: Represents 12,078 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 13, 2015.

F4: On September 28, 2011, the reporting person was granted 12,500 restricted stock units, of which 1/4th of the shares subject to the restricted stock units were issued on November 16, 2015 following vesting. The common stock into which such vested restricted stock units converted on November 16, 2015 is reported in Table I on this Form 4.